Angiotensin-converting enzyme inhibitors in coronary artery disease and preserved left ventricular systolic function: a systematic review and meta-analysis of randomized controlled trials.
about
Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology:The effectiveness of mobile-health technology-based health behaviour change or disease management interventions for health care consumers: a systematic reviewManagement standards for stable coronary artery disease in India.Management Protocols of stable coronary artery disease in India: Executive summary.Comparative Effectiveness of Renin-Angiotensin System Antagonists in Maintenance Dialysis Patients.Five-year prognosis in an incident cohort of people presenting with acute myocardial infarction.Renin-angiotensin-aldosterone system blockade for cardiovascular diseases: current statusAssessment and management of resistant hypertensionEffects of cardiac medications for patients with obstructive coronary artery disease by coronary computed tomographic angiography: results from the multicenter CONFIRM registry.Identifying opportunities for a medical group to improve outcomes for patients with coronary artery disease and heart failure: an exploratory study.The predicted impact of heart disease prevention and treatment initiatives on mortality in Lithuania, a middle-income countryAssociation between higher rates of cardioprotective drug use and survival in patients on dialysisRandomised comparison of zofenopril and ramipril plus acetylsalicylic acid in postmyocardial infarction patients with left ventricular systolic dysfunction: a post hoc analysis of the SMILE-4 Study in patients according to levels of left ventricularExplaining the increase in coronary heart disease mortality in Syria between 1996 and 2006Potential of non-antiarrhythmic drugs to provide an innovative upstream approach to the pharmacological prevention of sudden cardiac death.Long term medical treatment of stable coronary disease.Traditional management of chronic stable angina.Regulation of the renin-angiotensin system in coronary atherosclerosis: a review of the literatureBayesian meta-analysis of tissue angiotensin-converting enzyme inhibitors for reduction of adverse cardiovascular events in patients with diabetes mellitus and preserved left ventricular function.A concise description of cardioprotective strategies in doxorubicin-induced cardiotoxicity.Therapeutic strategies in patients with chronic stable coronary artery disease.Optimal medical therapy, lifestyle intervention, and secondary prevention strategies for cardiovascular event reduction in ischemic heart disease.Targeting the renin angiotensin system in dialysis patients.Angiotensin-Converting Enzyme Inhibitors (ACEIs) and Angiotensin-Receptor Blockers (ARBs) in Patients at High Risk of Cardiovascular Events: A Meta-Analysis of 10 Randomised Placebo-Controlled Trials.Dual renin-angiotensin-aldosterone blockade: promises and pitfalls.Phase 4 Studies in Heart Failure - What is Done and What is Needed?Efficacy of Angiotensin-Converting Enzyme Inhibitors and Angiotensin-Receptor Blockers in Coronary Artery Disease without Heart Failure in the Modern Statin Era: a Meta-Analysis of Randomized-Controlled Trials.Secondary preventive medication use in a prevalent population-based cohort of acute coronary syndrome survivors.Renin-angiotensin system antagonists and clinical outcomes in stable coronary artery disease without heart failure.Medical management of advanced heart failureRisk-Benefit Assessment of Carotid Revascularization
P2860
Q22242896-B78CB03F-FD58-435F-8393-15347006ACB9Q28709939-A132A798-1B1E-48F1-912E-EA8D4C200A39Q30239853-A77E8E74-AD92-4B04-89C9-AB4BB29F35DDQ30240155-7E000B13-04FE-4634-BB9A-92F5395DAEDCQ33730477-FCD5D9E7-0E1B-4F81-8FAA-57E0AB78C5C4Q34058695-02A82A96-BC73-45B1-AEBC-F65DCDCFF4E2Q34124779-D4C0268C-751D-4C17-8BCA-5C1809CF7A70Q34656780-430A8681-C55F-487A-B3D5-8FB922BF5BD0Q34778842-67F17CFD-4ED2-4513-8B7C-C497985F1648Q35119450-DAD3B921-4E36-4F2E-9A27-96F2AD95F163Q35565814-BE81A562-DAF6-49B2-8B8E-0221377D201FQ35812557-D8BBFF11-1501-48EB-8A03-FE6D87B7EA72Q35942936-603D9FEF-BEC3-497E-86B6-E71C0A6DA9F7Q36360138-7EE2CD0C-12DE-4404-A722-CE52DC9AC1ABQ36802605-484DE4F8-57A5-4FD5-9CA6-F070A65DB7F6Q36969811-50418E2D-19FD-4CC9-8E96-1E47F5C9751CQ37015962-CF4224B9-E219-4EF2-8702-7BF142926F2DQ37058920-4E4FE471-2F44-4902-95F5-B382E2D750C7Q37104532-64405D38-03C2-4DEC-9CE4-EDB5032A592FQ37629634-4A242461-EE5B-415D-B309-D8231DCF5CB4Q37759029-111063EC-9BB7-4BB2-8ABF-0FAAC7E68C7CQ37873815-7584183C-BBC4-468F-A078-1BBE44870FABQ37891151-A8A87796-7BDE-4637-A4A2-789E0AA6A8A6Q38168840-7C4C9421-599D-4DB5-B44A-B6528D36281DQ38275264-9A096623-6F03-4836-B76D-5AC4133FD451Q38859866-9D1E1A36-5C9F-4108-BDF8-3A21EF1C8B2AQ40009748-84524CA0-37E6-449D-B97A-35D09937F82FQ40636989-31FA2F97-67B7-41D2-A3A5-72B66315304FQ46202427-DF9BFE12-676A-4346-B112-AAF4125A09D3Q57396286-9270FF97-23A9-4F98-BE21-7E7F158C8E91Q58588652-2BF09D07-4BEB-46D1-B473-141E6D56B26C
P2860
Angiotensin-converting enzyme inhibitors in coronary artery disease and preserved left ventricular systolic function: a systematic review and meta-analysis of randomized controlled trials.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Angiotensin-converting enzyme ...... randomized controlled trials.
@ast
Angiotensin-converting enzyme ...... randomized controlled trials.
@en
type
label
Angiotensin-converting enzyme ...... randomized controlled trials.
@ast
Angiotensin-converting enzyme ...... randomized controlled trials.
@en
prefLabel
Angiotensin-converting enzyme ...... randomized controlled trials.
@ast
Angiotensin-converting enzyme ...... randomized controlled trials.
@en
P31
P1476
Angiotensin-converting enzyme ...... randomized controlled trials.
@en
P2093
Imad M Tleyjeh
W Douglas Weaver
P304
P356
10.1016/J.JACC.2005.11.073
P407
P577
2006-03-29T00:00:00Z